POCI
Precision Optics Corporation, Inc.NASDAQHealthcareAs of 2026-04-09
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
3.27
P/S
1.25
EV/EBITDA
-5.27
DCF Value
$-19.26
FCF Yield
-10.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
9.7%
Operating Margin
-27.6%
Net Margin
-28.3%
ROE
-60.6%
ROA
-30.2%
ROIC
-49.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $7.4M | $-1.8M | $-0.23 |
| Q1 2026 | $6.7M | $-1.6M | $-0.21 |
| Q4 2025 | $6.2M | $-1.4M | $-0.19 |
| FY 2025 | $19.1M | $-5.8M | $-0.85 |
Analyst Ratings
View AllConsensus
—
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.33
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.